conivaptan hydrochloride

conivaptan hydrochloride (VAPRISOL) is an FDA-listed pharmaceutical active ingredient. Associated with CUMBERLAND PHARMACEUTICALS INC. Route of administration: injection. Current US regulatory status: approved.

VAPRISOL is a marketed brand name for conivaptan hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

conivaptan hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.